Arjuna Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Arjuna Capital's DGX Position: Q3 2026 in Review
Arjuna Capital increased its Quest Diagnostics (DGX) stake by 89% in Q3 2026, buying an estimated $1.71M and bringing the position to 15,694 shares worth $3.66M. The position accounts for 0.82% of the portfolio, ranked #35.
Arjuna Capital first reported a position in DGX in Q3 2022 and has held it in 17 quarters since. The position peaked at $3.87M in Q3 2024. 722 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Arjuna Capital held 15,694 shares of Quest Diagnostics worth $3.66M as of Q3 2026.
- Arjuna Capital bought 7,396 Quest Diagnostics shares in Q3 2026, an estimated $1.71M.
- Quest Diagnostics made up 0.82% of Arjuna Capital's portfolio in Q3 2026, its #35 holding.
- Arjuna Capital first reported a position in Quest Diagnostics in Q3 2022 and has held it in 17 quarters since.
- Arjuna Capital's Quest Diagnostics position peaked at $3.87M in Q3 2024.
- 722 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Arjuna Capital's 13F filing for Q3 2026, filed 3 Nov 2026.